98%
921
2 minutes
20
Aims: To determine the factors influencing awareness about beta-thalassemia in the population.
Settings And Design: A cross sectional study was conducted by the Department of Pathology, AIIMS, Jodhpur.
Methods And Material: The study population included participants with medical as well as non-medical background, to ensure representation of all sections of the society. Data was collected in an objective survey form drafted in simple language.
Statistical Analysis Used: The data was analysed using Microsoft Excel and Chi Square Test for Independence was performed.
Results: The participants with a positive family history had significantly more knowledge compared to others, but even these participants didn't have complete knowledge about the disease. Age and gender had no significant impact on the results. The mode of occurrence of beta-thalassemia was known to less than half of the participants, with even less number being aware of the fact that diagnosis of beta-thalassemia can be made before birth. Participants with a medical background were aware that there were several forms of beta-thalassemia, but the knowledge about treatment options was limited.
Conclusions: Various factors affect the awareness in the general population, which has an effect on the outcome of screening programmes. There is a need for successful implementation of a screening programme for beta-thalassemia in order to reduce the financial burden that it imposes on healthcare facilities and to lessen the emotional burden on relatives of patients with the disease.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652196 | PMC |
http://dx.doi.org/10.4103/jfmpc.jfmpc_804_20 | DOI Listing |
Medicina (Kaunas)
August 2025
Medical Laboratory, Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj 16278, Saudi Arabia.
: Hemoglobinopathies are genetic disorders of hemoglobin and are among the most common inherited diseases. The prevalence rates of sickle cell disease and thalassemia in Saudi Arabia are higher than those in other countries in the Middle East. Saudi Arabia has launched many prevention programs such as a premarital screening program, genetic counseling programs, and neonatal screening in order to reduce the incidence of genetic diseases.
View Article and Find Full Text PDFJ Pak Med Assoc
August 2025
Final Year MBBS Student, Wah Medical College, Wah Cantt, Pakistan.
Patients with beta thalassemia major can make an uneventful and miraculous recovery after bone marrow transplantation despite lacking a sibling donor. The once widely accepted belief that only a transplant received from a sibling or mother would lead to a successful outcome has been challenged by the advent of new approaches and drugs. We present the case of a 15-yearold girl who received stem cells from her father and, despite suffering an attack of acute graft versus host disease (aGVHD) and depression, still managed to achieve a 100% success rate.
View Article and Find Full Text PDFIndian J Med Res
May 2025
Thalassemia Prevention, Sankalp India Foundation, Bengaluru, Karnataka, India.
Background & objectives India carries a significant burden of hemoglobinopathies, with beta-thalassemia and sickle cell disease (SCD) carrier rates ranging from 3-40 per cent by region. Despite the importance of universal screening, widespread prevention is challenging due to socio-cultural stigma, low awareness, and poor follow up. Sankalp's thalassemia prevention program used targeted prenatal screening rather than mass or cascade screening.
View Article and Find Full Text PDFBMC Public Health
August 2025
Department of Anthropology, University of Delhi, Delhi, 110007, India.
Background: Thalassemia is one of the most common monogenic blood disorders worldwide and has a considerable public health burden on India, with a 3.74% prevalence of beta-thalassemia trait. Most ideally, this genetic disease can be managed by prevention through awareness, screening, and counselling.
View Article and Find Full Text PDFBlood Rev
July 2025
Division of Hematology & Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address:
β-thalassemia is a hereditary hemoglobinopathy characterized by ineffective erythropoiesis, chronic anemia, and iron overload. Improved survival rates due to advances in transfusion and iron chelation therapies have shifted the clinical burden toward managing complex, often acute, complications that commonly present to the emergency department (ED). This review provides an evidence-based, system-oriented framework for emergency physicians to recognize and manage β-thalassemia-related emergencies.
View Article and Find Full Text PDF